Tr. Spitzer et al., ANTIEMETIC STRATEGIES FOR HIGH-DOSE CHEMORADIOTHERAPY-INDUCED NAUSEA AND VOMITING, Supportive care in cancer, 6(3), 1998, pp. 233-236
Citations number
16
Categorie Soggetti
Oncology,Rehabilitation,"Health Care Sciences & Services
The treatment of nausea and vomiting in patients receiving high doses
of irradiation and/or chemotherapeutic agents as preparation for hemat
opoietic stem cell transplantation is discussed. Such patients have ve
ry high rates of both early and delayed emesis. Based on the available
evidence it is recommended that 5-MT3 receptor antagonists be used to
combat emesis in this setting. Continued research is also required to
define the optimal antiemetic strategy for these patients.